Braves lock up starting pitcher entering 17th season in MLB originally appeared on The Sporting News. Add The Sporting News as a Preferred Source by clicking here.
The Atlanta Braves are making it clear that last season is not something they plan to relive.
Advertisement
Instead of waiting to see how things unfold, Atlanta moved quickly to secure the one arm that stabilized everything a year ago. Chris Sale has agreed to a one year, $27 million extension that includes a club option for 2028, keeping him from reaching free agency next winter and giving the Braves a proven ace at the front of their rotation.
For a team that finished 76-86 in 2025 and is already dealing with spring injuries to young starters, this is about certainty as much as talent.
From injury questions to Cy Young answers
Not long ago, Sale’s career felt like a series of medical updates. Tommy John surgery. A fractured rib. A broken finger on a line drive. Even a broken wrist from a bicycle accident. Seasons that once featured 300 strikeouts turned into long stints on the injured list.
Advertisement
Then he got to Atlanta and everything changed.
In 2024, Sale finally captured the Cy Young Award that had eluded him for years. He went 18-3 with a 2.38 ERA and led the National League with 225 strikeouts across 177 and two-thirds innings. It was vintage Sale, the long, lean left-hander blowing fastballs past hitters and snapping off sliders that seemed to disappear.
He followed that up in 2025 with a 2.58 ERA over 125 and two-thirds innings, striking out 165 and walking just 32. A rib injury limited his workload, but when he took the mound, he was still dominant.
More: Cardinals pitcher gives up homer with the wrong baseball in his hand
Advertisement
Why this move matters right now
This extension is not a sentimental reward for past accomplishments. It is a practical decision rooted in the present.
Atlanta has already seen injuries thin its pitching depth this spring. Over 162 games, depth is tested. Having a veteran who has navigated playoff races, October pressure and nearly every possible setback gives the Braves something they desperately need: stability.
Sale turns 37 at the end of March. He is entering his 17th big league season. Yet the radar gun still flashes mid 90s. His slider is still one of the toughest pitches in baseball to square up. The numbers suggest this is not smoke and mirrors. He remains an elite strikeout arm with command.
Advertisement
A calculated risk worth taking
There is always risk when investing heavily in a pitcher with a history of injuries, especially one in his late 30s. The Braves understand that. They also understand what they look like without him.
In a season when little went right in 2025, Sale was one of the few consistent bright spots. Locking him in sends a message to the clubhouse and the fan base that the organization believes it can contend again.
Atlanta is not paying for nostalgia. It is paying for performance. If Sale stays healthy, the Braves have an ace capable of leading a turnaround. If he does not, the gamble becomes expensive.
Advertisement
For now, though, the Braves are choosing belief. And they are putting that belief in the left arm that has defined an era of pitching excellence.
More MLB news: